Explore more Johnson & Johnson sites:
Share
Back to top
Johnson & Johnson
-
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
Mobilizing to help coworkers in need. Increasing diverse representation in clinical trials. Advocating on behalf of people living with life-altering medical conditions. Learn about the extraordinary ways these trailblazers made a difference in 2022.
-
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
-
We spoke to a scientist behind a treatment for the disease that was recently FDA-approved for adolescents ages 12 to 18 to learn how it could give them new hope.
-
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
-
Johnson & Johnson earned the #2 spot on the Access to Medicine Index, an important measurement of the company's longstanding commitment to make lifesaving medicine available and accessible to those who need it most.
-
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
-
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Hispanic Heritage Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.
-
ON NOW
Johnson & Johnson Executive Jennifer Taubert Named to Fortune’s 2022 Most Powerful Women List
The company leader has been named to the prestigious list—which honors 50 women at the top of their industries—for the seventh year in a row. -
Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.
-
A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.
-
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
-
Two new Johnson & Johnson initiatives aim to remove the obstacles people of color and the LGBTQIA+ community have historically faced in getting help with mental illness. The head of Janssen Neuroscience, Courtney Billington, explains why breaking these barriers is a priority—and a personal mission.
-
Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
